Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Ekf Diagnostics Holdings Plc LSE:EKF London Ordinary Share GB0031509804 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.60 -1.98% 79.40 78.60 80.40 80.80 78.40 80.80 12,689,078 16:35:08
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 44.9 5.5 0.8 98.0 361

Ekf Diagnostics Share Discussion Threads

Showing 2876 to 2897 of 3350 messages
Chat Pages: Latest  122  121  120  119  118  117  116  115  114  113  112  111  Older
DateSubjectAuthorDiscuss
03/1/2021
05:19
21 great Welsh firms to watch in 2021 30th December 2020 From tech to manufacturing and cleaning to TV production Wales has firms with great growth potential EKF Diagnostics is a gem in Wales' life sciences sector. The diagnostics sector never been in better shape with its immediate testing capacity for diseases such as diabetes and other underlying conditions that can make people more susceptible to Covid-19. 2020 saw EKF, which is headquartered in Penarth but operates globally, producing and distributing Covid-19 testing collection kits, which will be ramped up further in early 2021 with new production facilities in the Vale of Glamorgan. hTTps://www.business-live.co.uk/enterprise/21-great-welsh-firms-watch-19424165
wan
01/1/2021
00:18
Happy New Year to wan and all !! Thanks for a great thread
9degrees
31/12/2020
12:00
We're up 8%+ and not a word from anyone esp the guy with the Tong. He'll accuse us of ramping with our silence soon. Big news in Jan to take us to to new heights IMHO GLALTH
mg1982
31/12/2020
07:57
Also pleased to see Octopus emerging with a notable stake, it should be interesting to see if they add further and are joined by others!
hastings
31/12/2020
07:45
The Octopus Investment is indeed interesting, because the CEO mentioned during the recent meeting that (from memory) a number of high profile fund investors were showing increased interest in EKF. One aspect that I have been maintaining as perhaps being under-appreciated, is the value creation from the Mount Sinai partnership, for which the pipeline 'extends' beyond the next value delivery opportunity, Trellis Health. Such Investment Fund interests suggests that EKF is indeed coming to the attention of a wider range of investment audience.
wan
30/12/2020
23:03
Tonight's late RNS indicates that Octopus Investments have been buying and are now a major shareholder - they have 3.1% with 14.1m shares: Https://www.investegate.co.uk/ekf-diagnostics-hldg--ekf-/rns/holding-s--in-company/202012301756012007K/
rivaldo
30/12/2020
08:58
I am hoping for an early January trading update from EKF. This company is massively undervalued with its suite of income generating assets strong cash position and link with Mount Sinai. I do feel they are vulnerable to a bid at current levels AIMHO GLA BTG
btgman
30/12/2020
03:00
https://www.dailymail.co.uk/money/billsguides/article-9097103/MARKET-REPORT-MyHealthChecked-soars-Covid-stamp-approval.html
mirandaj
29/12/2020
08:26
Given the risks, not to mention the increased transmissibility of the new variant, you would think that all responsible companies would want to eliminate as much risk as possible and keep their employees, and the general public, as safe as possible - Transporting samples safely MyHealthChecked takes safety seriously and our sample transportation procedures meet or exceed all local regulations. In the case of our COVID tests for example, your sample is preserved in a special vial, a PrimeStore® MTM (which stands for a molecular transport media) approved by Public Health England. This deactivates any virus in the transportation tube, whilst retaining the stability of the sample. It’s clever technology that creates a “snapshot in time” for your sample, preserving and stabilising DNA and RNA, and keeping postal workers safe from infection if your test contains contagions. hTTps://myhealthchecked.com/trust-safety-myhealthchecked/
wan
29/12/2020
07:50
I should have added the remainder of the RNS - Commenting on the approval, Penny McCormick, CEO of MyHealthChecked Plc, said: "Our COVID-19 testing service launched on 2 December and has gathered momentum through the month. As we are already providing Fit to Fly documentation, our inclusion on the Government's official list of Test to Release providers will further enhance the service that we can provide to travellers departing the UK, and flying into the country. Our priority is to provide an excellent service to customers, which includes a robust web App and user interface that is compliant and provides a positive user experience. We have been confident that our process would meet the Government's requirements, and we will be rolling out the enhanced system and service from January." "Alongside this further COVID-19 related development, our team continues with its initial development and rollout plans for the new portfolio of home-use genomic tests, and we will be providing an update on our Q1 launch plans in the coming weeks." hTTps://uk.advfn.com/stock-market/london/concepta-CPT/share-news/MyHealthChecked-PLC-Approval-for-UK-Government-Tes/83986948
wan
29/12/2020
06:51
https://industrytoday.co.uk/pharmaceutical/pregnancy-point-of-care-testing-market-to-reflect-impressive-growth-rate-during-2020-2027 The Prominent/Emerging Players in the Pregnancy Point of Care Testing Market Research includes:Abbott Laboratories  Quidel Corporation  BIOSYNEX SA  Prestige Brands Holdings, Inc.  EKF Diagnostics Holdings plc  bioMerieux SA  NOW Diagnostics Inc  Procter and Gamble Co.  NG BIOTECH SAS  Swiss Precision Diagnostics https://www.news-medical.net/QuPID-Pregnancy-Test-from-EKF-Diagnostics
mirandaj
28/12/2020
08:42
This article in today's Times suggests COVID-19 testing has a long way to go in terms of both quantities and duration - for non-subscribers, here's the highlights: Https://www.thetimes.co.uk/edition/business/bosses-seek-airport-style-covid-tests-for-workers-30ql7qrxv "Relaxing social distancing in favour of more frequent coronavirus tests could help workplaces return to normal and boost productivity, Britain’s biggest lobby group has told the government." "Retailers including Asos and Next have said that productivity in their warehouses has been limited by social distancing requirements. As a result, they have had to extend delivery times because it takes longer to pick and pack orders. Ocado, the online grocer, has tested staff entering its robotic warehouse after buying 100,000 kits from China. The John Lewis Partnership introduced testing this month for 1,000 staff at its distribution centre and 40 stores three times a week. The government is considering a range of incentives and subsidies to help with the costs of testing, according to The Mail on Sunday which first reported the CBI’s discussion of more testing. It is thought frequent testing could help get businesses back on their feet while waiting for vaccinations. A pilot of about 30 firms, including John Lewis, is already in operation while a number of private businesses offering rapid tests have sprung up. Companies have been urged to consider whether they would want to make testing mandatory and how frequently they would test their employees."
rivaldo
26/12/2020
18:57
Covid testing capacity expected to fall short as UK cases surge in the FT Government document warns of scarcity in kits when schools and universities return in January The UK may not have enough coronavirus tests to meet surging demand in the coming weeks, according to an internal government document, as the new strain of Covid-19 sends cases soaring. Demand for the conventional polymerase chain reaction (PCR) tests used by the NHS Test and Trace programme was predicted to outstrip supply in the week to Christmas by up to 50,000 tests a day, according to government calculations made last week and seen by the Financial Times. The forecast that demand could exceed 700,000 tests a day, when capacity currently stands at 650,000, was made before the effect of the new strain of Covid-19 was fully understood. Since those calculations were made, Boris Johnson, the UK prime minister, has said that the mutation could be up to 70 per cent more transmissible than the earlier strain. The warning caused international alarm and has resulted in more than 40 countries imposing travel bans on Britain. Allan Wilson, who heads the Institute of Biomedical Science, a professional body, said that while the new rules restricting family visits at Christmas might relieve pressure in the next few days, “increased demand from this new strain of Covid-19 is likely to offset the decrease”. “We can only hold our breath and see what happens,” he said. A surge in demand for Covid-19 tests in the run-up to Christmas, rising from around 380,000 a day on December 14, has been fuelled by a concerning rise in cases, particularly in south-east England, as well as large numbers of people without symptoms ordering tests before they visit family members. That has put strain on the testing system, with many people taking to social media to report they had been unable to order home testing kits over the weekend or been sent miles to reach the nearest available drive-in centre. The government increased capacity to about 593,000 tests a day at the end of last week and will raise it by a further 100,000 a day next week, according to the document, with capacity due to increase to 788,000 by January 19. Coronavirus in 2021: what we do and don't know Nonetheless, NHS Test and Trace predicts that demand might outstrip testing capacity several times next month, as the virus continues to spread and students return to school and university. The Department of Health and Social Care said there was capacity to respond to increases in demand and “people can have confidence that if they have symptoms and need a test, they can get one”. But it insisted that “individuals should book PCR tests only if they had symptoms of coronavirus: a high temperature, a new continuous cough or a loss or change to sense of smell or taste”. “It is vital everyone continues to play their part by following the rules and remembering the ‘hands, face, space’ guidance, and coming forward for community testing if it is offered locally, ” it said. Meanwhile, the Medicines and Healthcare products Regulatory Agency, the UK regulator, has for the first time approved rapid Covid-19 tests for use at home by members of the public, according to two people with knowledge of the decision.
mginvestor
26/12/2020
08:54
I hope all readers are staying safe and well, and enjoying the Christmas break, even if that's in a somewhat more restricted way (as mine has been and is). The following news is again concerning, but importantly it perhaps highlight the significant difference of using PrimeStore MTM which inactivates infectious viruses and provides safer and more reliable testing - Staff at UK coronavirus testing lab hit by outbreak of disease Whistleblower claims safety measures breached at Milton Keynes facility where 20 staff affected Staff at the UK’s biggest testing lab in Milton Keynes have been hit by an outbreak of coronavirus as the country struggles to contain the soaring number of infections. Cases have been reported in three of the four scientific teams at Milton Keynes Lighthouse Laboratory, Sky News said on Christmas Eve. Sky said there had also been cases among the admin and warehouse departments. It is believed that, as a result of the outbreak, about 20 members of a 70-person lab team are isolating. The site is being asked to process 70,000 tests a day to keep up with rising demand. A whistleblower told Sky News that Covid safety measures had been breached. The lighthouse laboratories are large-scale centres set up to try to increase testing capacity. New testing sites were opened in two London university laboratories in December, and another will be opened in the capital shortly, according to Department for Health and Social Care (DHSC) officials. A spokesperson said: “NHS Test and Trace continues to test record numbers of people, and people can have confidence that if they have symptoms and need a test, they can get one. “We are delivering an unprecedented volume of tests – more than 450,000 yesterday alone – and during periods of high demand, our focus is ensuring that anyone with symptoms can get a test. “All our test sites and our home test service will be available for bookings as normal over the Christmas period.” Full story - hTTps://www.theguardian.com/world/2020/dec/24/staff-at-uk-coronavirus-testing-lab-hit-by-outbreak-of-the-disease Sky News - hTTps://news.sky.com/story/covid-19-major-uk-testing-lab-suffers-coronavirus-outbreak-after-claims-of-safety-breaches-12172290
wan
24/12/2020
13:01
i don't think that the tax paid on the dividend in specie can be added to the dividend quantum for cgt base cost purposes but i am happy to be wrong
richman777114
23/12/2020
13:50
RE: In specie dividend. In my calculation, the base cost of the new shares becomes the value on which you paid tax PLUS the tax you paid on the 'dividend'. This accounts for the shares whch you would have to sell to pay the tax. In effect, if you have not sold them you have 'repurchased' them from the tax man at that cost.
boadicea
23/12/2020
10:15
Awesome - it's just the small matter of price not acting right but that doesn't matter does it.
tongosti
23/12/2020
08:43
As EKF investors, we do also need to cast our eye beyond Covid-19 testing, especially now that Longhorn, and indeed EKF, has been put firmly on the testing/surveillance map. One such example - African Swine Fever (ASFv) A virus ravaging the global pork industry. Improving testing to stop the spread. Cleared by the U.S. FDA for microbial inactivation, PrimeStore® MTM has been under extreme testing at the USDA Foreign Animal Disease Diagnostic Laboratory (FADDL) at Plum Island for the last three years. PrimeStore® MTM is already being used worldwide for animal surveillance, but the most recent testing results are pending publication. In consultation with the FADDL leadership, a special configuration of PrimeStore® MTM will be launched to ensure sample to PrimeStore® MTM ratios are appropriately maintained by end users when testing samples that might contain High Consequence Pathogens (HCP) – such as ASFv, Classical Swine Fever (CSFv) and Foot and Mouth Disease (FMDv). The new configuration will be known as PrimeStore® MTM HCP. hTTps://lhnvd.com/african-swine-fever Belgium declared African swine fever disease free 22 Dec 2020 It is the restoration of this international free status by the OIE that will make it possible to initiate negotiations with third countries on the lifting of the current embargoes on Belgian pork. Nevertheless, it remains important to be vigilant. African swine fever is still circulating in Eastern Europe and the virus spread further to the border area in Germany with Poland in September. Our country, like all European countries, is closely monitoring the situation in order to prevent a second introduction of the virus. Although the disease has now been eradicated, the Walloon Region in the south of the province of Luxembourg still maintains strict monitoring and control measures. In the future, they will be gradually phased out, according to an already established strategy. hTTp://outbreaknewstoday.com/belgium-declared-african-swine-fever-disease-free-25823/ The US are on the case - A Race To Get In Front Of African Swine Fever By JENNIFER SHIKE December 15, 2020 As African swine fever (ASF) rages in Vietnam, the U.S. pork industry, through a $1.7 million USDA Foreign Agricultural Service grant, is learning more about this deadly virus from what pork producers in Vietnam are facing now. The Swine Health Information Center’s (SHIC) Vietnam project is studying ASF in real time as the disease breaks on farms across the country. With the National Pork Producers Council’s (NPPC) help, SHIC obtained a grant with a two-fold mission to help with education, webinars, meetings and outreach information about ASF in Vietnam and to conduct field projects to learn valuable lessons about how this virus spreads. Getting Ahead Of The Virus “With ASF, we've got an opportunity in Vietnam to not chase it, but get in front of it and learn the lessons about all of those things with management control, epidemiology, etc., before it gets here,” explained Paul Sundberg, executive director of SHIC, during a SHIC Talk podcast. Lessons Learned from COVID-19 Surveillance and testing will be critical in efforts to prepare for and prevent ASF. Wagstrom said many lessons were learned from the COVID-19 pandemic. “We're nine months into an outbreak and they're still struggling with what testing means, how to get people tested, how accurate are some of their tests, etc. It would be criminal for us not to have a surveillance scheme set up and have the appropriate tests when we know what pathogen we're dealing with,” Wagstrom said. COVID-19 was a brand-new pathogen, so the Department of Public Health didn't have a test. But the U.S. pork industry has the luxury of knowing what it is worried about – African swine fever, Wagstrom explained. Now, the industry needs to keep expanding its test types. NPPC continues to work closely with USDA and the state animal health officials trying to put together surveillance schemes before an outbreak occurs. Another lesson learned from the supply chain disruptions caused by COVID-19 is that the pork industry needs to do more work in the area of depopulation and disposal. “We didn't have the resources in place to be ready to have a large-scale depopulation effort, and that comes back to industry, states and federal government,” Pyburn said. “We need to make sure we've got a plan, and not only a plan, but also the resources to fulfill that plan and get it done in a timely manner on our farms so that we don't run into welfare issues.” Full story - hTTps://www.porkbusiness.com/news/hog-production/race-get-front-african-swine-fever
wan
23/12/2020
07:55
Exactly Wan testing testing and more testing is what is on the way this is currently being missed within EKF share price. On top of this EKF's basket of other products is staggering I have said before 2021 will be a more profitable year than 2020 AIMHO GLA BTG
btgman
23/12/2020
07:50
Edit to above post
wan
23/12/2020
07:47
An example of the demand for antibody tests and the fact that testing across all types will continue beyond 2021, and not least of all PCR testing - Antibody Testing Kits A Tender Notice by DEPARTMENT OF HEALTH AND SOCIAL CARE (DHSC - TEST AND TRACE) Type Contract (Products) Duration 2 year Value £30M-£100M Sector HEALTH Published 21 Dec 2020 Delivery 01 Feb 2021 to 01 Feb 2023 Deadline 21 Jan 2021 00:00 Description Owing to the developing nature of our response to COVID-19 the Contracting Authority is establishing a Dynamic Purchasing System to facilitate the procurement of Testing Kits, technologies or Devices for the detection, analysis or monitoring of COVID-19 Antibodies hTTps://bidstats.uk/tenders/2020/W52/741343488 Bodes well for interest in EKF's Kantaro antibody test kit.
wan
22/12/2020
13:04
so if the distribution based on fair value works out at say £2k then that is also the base cost of the distributed shares for cgt purposesobvs i'm not a tax adviser so usual caveats re DYOR etc
richman777114
Chat Pages: Latest  122  121  120  119  118  117  116  115  114  113  112  111  Older
ADVFN Advertorial
Your Recent History
LSE
EKF
Ekf Diagno..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210420 20:48:09